CD8A and neuroblastoma: idMMR neuroblastoma cells exhibited a decrease in MHC class I gene expression, and anti-PD1 therapy did not confer any additional therapeutic benefit, despite increased CD8+ T cell infiltration in response to MMR induction in these tumors (Figure 2F).